Evidence map›Paper›PMID 28387241›Full record

ArticleScientific reports2017

An unbiased index to quantify participant's phenotypic contribution to an open-access cohort.

Yingleong Chan, Michael Tung, Alexander S Garruss, Sarah W Zaranek, Ying Kai Chan, Jeantine E Lunshof, Alexander W Zaranek, Madeleine P Ball, Michael F Chou, Elaine T Lim and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yingleong ChanDepartment of Genetics, Harvard Medical School, Boston, MA 02115, USA.
Michael TungDepartment of Genetics, Harvard Medical School, Boston, MA 02115, USA.
Alexander S GarrussDepartment of Genetics, Harvard Medical School, Boston, MA 02115, USA.
Sarah W ZaranekCuroverse Inc, Somerville, MA 02144, USA.
Ying Kai ChanDepartment of Genetics, Harvard Medical School, Boston, MA 02115, USA.
Jeantine E LunshofDepartment of Genetics, Harvard Medical School, Boston, MA 02115, USA.
Alexander W ZaranekCuroverse Inc, Somerville, MA 02144, USA.
Madeleine P BallPersonal Genomes.org, Boston, Massachusetts 02115, USA.
Michael F ChouDepartment of Genetics, Harvard Medical School, Boston, MA 02115, USA.
Elaine T LimDepartment of Genetics, Harvard Medical School, Boston, MA 02115, USA.
George M ChurchDepartment of Genetics, Harvard Medical School, Boston, MA 02115, USA.

Funding

Causal Transcriptional Consequences of Human Genetic VariationP50HG005550 · NHGRI · HARVARD MEDICAL SCHOOL · PI CHURCH, GEORGE M · 2010 to 2014
$19.0M
Training Program in Bioinformatics and Integrative GenomicsT32HG002295 · NHGRI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Peter J Park · 2001 to 2026
$15.8M
Center for Genomically Engineered OrgansRM1HG008525 · NHGRI · HARVARD MEDICAL SCHOOL · PI CHURCH, GEORGE M · 2015 to 2019
$10.2M
NHGRI NIH HHS P50 HG005550NHGRI NIH HHS RM1 HG008525NHGRI NIH HHS T32 HG002295
6 · The paper itself

Abstract

The Personal Genome Project (PGP) is an effort to enroll many participants to create an open-access repository of genome, health and trait data for research. However, PGP participants are not enrolled for studying any specific traits and participants choose the phenotypes to disclose. To measure the extent and willingness and to encourage and guide participants to contribute phenotypes, we developed an algorithm to score and rank the phenotypes and participants of the PGP. The scoring algorithm calculates the participation index (P-index) for every participant, where 0 indicates no reported phenotypes and 100 indicate complete phenotype reporting. We calculated the P-index for all 5,015 participants in the PGP and they ranged from 0 to 96.7. We found that participants mainly have either high scores (P-index > 90, 29.5%) or low scores (P-index < 10, 57.8%). While, there are significantly more males than female participants (1,793 versus 1,271), females tend to have on average higher P-indexes (P = 0.015). We also reported the P-indexes of participants based on demographics and states like Missouri and Massachusetts have better P-indexes than states like Utah and Minnesota. The P-index can therefore be used as an unbiased way to measure and rank participant's phenotypic contribution towards the PGP.

Indexed as

PhenotypeAlgorithmsCohort StudiesDiseaseFemaleGenome, HumanGeographyHumansMaleQuantitative Trait, HeritableSurveys and QuestionnairesUnited States

Identifiers

PMID28387241
PMCPMC5384003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.